PreventionGenetics' Genetic Testing is Now Covered for Over 100 Million US Residents
PreventionGenetics is pleased to announce that as of November 15, 2019, we are in-network with seven new insurers. This announcement is a reflection of PreventionGenetics commitment to providing the highest quality genetic testing to all patients.
PreventionGenetics is excited to introduce Rapid PGxome to our menu of whole exome sequencing (WES) tests. Rapid PGxome is WES with an expedited average turnaround time of 14 days. Our Rapid PGxome is ideal for situations where a rapid diagnosis is essential, typically patients with neonatal, infantile or early childhood onset severe disorders.
Skip the CMA, Exome-Wide CNV Analysis Now Available at PreventionGenetics
At PreventionGenetics, all next generation sequencing (NGS) panels include CNV detection for the genes within the panel. We are now pleased to announce an expanded option for PGxome-based defined and custom panels: Exome-Wide CNV Analysis. PreventionGenetics’ Exome-Wide CNV Analysis uses exome sequencing data to identify chromosomal imbalances similar to those detected by CMA. The genes from the selected panel receive the same CNV analysis as previously offered (CNVs of four or more exons are detected with sensitivity greater than 95%); with the Exome-Wide CNV Analysis added, the remainder of the exome is analyzed for CNVs as well.
Enhancing Your Experience with Us - Introducing myPrevent Support Portal
At PreventionGenetics customer service has always been important to us. We have been working hard to make it even better. On October 21, all your online communication will be handled using our new streamlined support process.